Skip to main content
SpringerLink
Log in

Adverse Reactions and Interactions of the Neuromuscular Blocking Drugs

  • Review Article
  • Adverse Drug Experience Review
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

Summary

The adverse reactions seen following administration of neuromuscular blocking agents are mainly cardiovascular. Due to the lack of specificity for the nicotinic receptor at the neuromuscular junction, these agents may interact with receptors in autonomic ganglia and muscarinic receptors in the heart. Furthermore, muscle relaxants may have histaminereleasing properties. The cardiovascular effects vary with potency and specificity of the drug, depending mainly on the chemical structure. Pancuronium, fazadinium and especially gallamonium block cardiac muscarinic receptors, and tachycardia may be seen. Atracurium, metocurine and in particular d -tubocurarine have histamine-releasing properties and may cause flushing, hypotension and tachycardia. Vecuronium has no effect on the cardiovascular system. The effect of succinylcholine on heart rate differs between children, where bradycardia is seen, and adults in whom tachycardia may follow. However, bradycardia may occur in adults following a single dose. Succinylcholine increases plasma potassium, especially in patients with nerve damage, and arrhythmias may be observed. The neuromuscular adverse effects of succinylcholine, such as fasciculations and increased gastric and intraocular pressure, may be prevented by precurarisation.

Many drugs interact with neuromuscular blocking agents and there is often a potentiation of the neuromuscular effect. This is of clinical importance in the case of antibiotics, inhalational anaesthetics, lithium and cyclosporin. Difficulty in reversing the block may occur with calcium channel blockers and polymyxin. However, some drugs, such as phenytoin, carbamazepine and lithium, may cause resistance to neuromuscular blocking agents. Furthermore, clinically important interactions exist between individual neuromuscular blocking drugs. Precurarisation with a non-depolarising drug prolongs the onset of succinylcholine, and conversely a prolonged effect of non-depolarising drugs is seen following succinylcholine. The effect of succinylcholine is markedly prolonged if the drug is administered during recovery from pancuronium blockade or following neostigmine for reversal. Succinylcholine is hydrolysed by plasma cholinesterase, and drugs which decrease the activity of this enzyme may produce a prolonged block, i.e. contraceptive pills, cyclophos-phamide, echothiopate and organophosphate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aldrete JA. Allergic reaction after atracurium. British Journal of Anaesthesia 57: 929–937, 1985

    Article  PubMed  CAS  Google Scholar 

  • Anderson KA, Marshall RJ. Interactions between calcium entry blockers and vecuronium bromide in anaesthetised cats. British Journal of Anaesthesia 57: 775–781, 1985

    Article  PubMed  CAS  Google Scholar 

  • Argov Z, Mastaglia FF. Disorders of neuromuscular transmission caused by drugs. New England Journal of Medicine 301: 409–413, 1979

    Article  PubMed  CAS  Google Scholar 

  • Azar I, Cottrell J, Gupta B, et al. Furosemide facilitates recovery of evoked twitch responses after pancuronium. Anesthesia and Analgesia 59: 55–57, 1980

    PubMed  CAS  Google Scholar 

  • Azar I, Kumar D, Betcher AM. Resistance to pancuronium in an asthmatic patient treated with aminophylline and steroids. Canadian Anaesthetists Society Journal 29: 280–282, 1982

    Article  PubMed  CAS  Google Scholar 

  • Baird WLM, Savage DS. Vecuronium: the first years. In Norman (Ed.) Neuromuscular blockade, Clinics in anaesthesiology, Vol. 3, No. 2, pp.347–360, WB Saunders, London, 1985

    Google Scholar 

  • Baraka A, Yazigi A. Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturient. Anesthesiology 67: 806–808, 1987

    Article  PubMed  CAS  Google Scholar 

  • Bikhazi GB, Leung I, Foldes FF. Interaction of neuromuscular blocking agents with calcium channel blockers. Anesthesiology 57: A268, 1982

    Article  Google Scholar 

  • Bishop MJ, Hornbein TF. Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure. Anesthesiology 58: 384–386, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bodley PO, Halwax K, Potts L. Low plasma pseudocholinesterase levels complicating treatment with phenelzine. British Medical Journal 3: 510–512, 1969

    Article  PubMed  CAS  Google Scholar 

  • Bowman WC. Non-relaxant properties of neuromuscular blocking drugs. British Journal of Anaesthesia 54: 147–160, 1982

    Article  PubMed  CAS  Google Scholar 

  • Cullen DJ. The effect of pretreatment with non-depolarizing muscle relaxants on the neuromuscular blocking action of succinylcholine. Anesthesiology 35: 572–578, 1971

    Article  PubMed  CAS  Google Scholar 

  • Cuthbert MF. The effect of quinidine and procainamide on the neuromuscular blocking action of suxamethonium. British Journal of Anaesthesia 38: 775–779, 1966

    Article  PubMed  CAS  Google Scholar 

  • Doll DC, Rosenberg H. Antagonism of neuromuscular blockade by theophylline. Anesthesia and Analgesia 58: 139–140, 1979

    Article  PubMed  CAS  Google Scholar 

  • Donati F, Bevan DR. Suxamethonium — current status. In Norman (Ed.) Neuromuscular blockade, Clinics in anaesthesiology, Vol. 3, No. 2, pp. 371–386 Saunders, London, 1985

    Google Scholar 

  • Dretchen KL, Morgenroth VH, Standaert FG et al. Azathioprine: effects on neuromuscular transmission. Anesthesiology 45: 604–609, 1976

    Article  PubMed  CAS  Google Scholar 

  • Driessen JJ, Crul JF, Vree TB, et al. Benzodiazepines and neuromuscular blocking drugs in patients. Acta Anaesthesiologica Scandinavica 30: 642–646, 1986

    Article  PubMed  CAS  Google Scholar 

  • Durant NN, Briscoe JR, Lee C, et al. The acute effects of hydrocortisone on nuromuscular transmission. Anesthesiology 57: A266, 1986

    Article  Google Scholar 

  • Durant NN, Katz RL. Suxamethonium. British Journal of Anaesthesia 54: 195–208, 1982

    Article  PubMed  CAS  Google Scholar 

  • Durant NN, Nguyen N, Katz RL. Potentiation of neuromuscular blockade by verapamil. Anesthesiology 60: 298–303, 1984

    Article  PubMed  CAS  Google Scholar 

  • Fahey MR, Rupp SM, Canfell C, et al. Effect of renal failure on laudanozine excretion in man. British Journal of Anaesthesia 57: 1049–1051, 1985

    Article  PubMed  CAS  Google Scholar 

  • Fisher MM, Baldo BA. Anaphylactoid reactions during anaesthesia. In Fisher (Ed.) Adverse reactions, Clinics in Anaesthesiology, Vol. 2, No. 3, pp. 677–692, Saunders, London, 1984

    Google Scholar 

  • Fisher MM, Munro I. Life-threatening anaphylactoid reactions to muscle relaxants. Anesthesia and Analgesia 62: 559–564, 1983

    Article  PubMed  CAS  Google Scholar 

  • Foldes FF, Arai T, Gentsch HH, et al. The influence of glucocorticoids on plasma cholinesterase (38219). Proceedings of the Society of Experimental Biology 146: 918–920, 1974

    CAS  Google Scholar 

  • Glidden RS, Martyn JAJ, Tomera JF. Azathioprine fails to alter the dose-response curve of d-tubocurarine. Anesthesiology 67: A357, 1987

    Article  Google Scholar 

  • Goldhill DR, Martyn JAJ. Succinylcholine-induced hyperkalemia. In Azar (Ed.) Muscle relaxants, pp. 93–114, Dekker Inc., New York, 1987

    Google Scholar 

  • Gramstad L. Atracurium, vecuronium and pancuronium in endstage renal failure. British Journal of Anaesthesia 59: 995–1003, 1987

    Article  PubMed  CAS  Google Scholar 

  • Gramstad K, Gjerlóv JA, Hysing ES, et al. Interaction of cyclosporin and its solvent, cremophor, with atracurium and vecuronium. British Journal of Anaesthesia 58: 1149–1155, 1986

    Article  PubMed  CAS  Google Scholar 

  • Greenan J. The cardio-oesophageal function. British Journal of Anaesthesia 33: 432–439, 1961

    Article  PubMed  CAS  Google Scholar 

  • Griffin JP, D’Arcy PF (Eds). A manual of adverse drug interactions, 2nd ed, pp. 300–307, Wright & Sons Ltd., Bristol, 1979

    Google Scholar 

  • Grogono AW. Anaesthesia for atrial defibrillation: effect of quinidine on muscular relaxation. Lancet 2: 1029–1040, 1963

    Google Scholar 

  • Hill GE, Wong KC, Hodges MR. Potentiation of succinylcholine neuromuscular blockade by lithium carbonate. Anesthesiology 44: 439–442, 1976

    Article  PubMed  CAS  Google Scholar 

  • Hill GE, Wong KC, Hodges MR. Lithium carbonate and neuromuscular blocking agents. Anesthesiology 46: 122–126, 1977

    Article  PubMed  CAS  Google Scholar 

  • Hughes R. Atracurium: an overview. British Journal of Anaesthesia 58: 2S–5S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Jones RM, Cashman JN, Casson WR, et al. Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium. Anesthesia and Analgesia 64: 1021–1025, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kambam JR, Dymond R, Krestow M. Effect of cimetidine on duration of action of succinylcholine. Anesthesia and Analgesia 66: 191–192, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kinjo M, Nagashima H, Duncalff D, et al. Nitrous oxide increases the neuromuscular blocking effect of nondepolarizing muscle relaxants. Anesthesiology 67: A372, 1987

    Article  Google Scholar 

  • Kronenfeld MA, Thomas SJ, Turndorf H. Recurrence of neuromuscular blockade after reversal of vecuronium in a patient receiving polymyxin/amikacin sternal irrigation. Anesthesiology 65: 93–94, 1986

    Article  PubMed  CAS  Google Scholar 

  • Laflin MJ. Interaction of pancuronium and corticosteroids. Anesthesiology 47: 471–472, 1977

    Article  PubMed  CAS  Google Scholar 

  • Laurence S. Oral dantrolene prevents rise of myoglobin due to suxamethonium. Anaesthesia 40: 907–910, 1985

    Article  PubMed  CAS  Google Scholar 

  • Lee C, deSilva AJC, Katz RL. Antagonism of polymyxin B induced neuromuscular and cardiovascular depression by 4-aminopyridine in the anesthetized cat. Anesthesiology 49: 256–259, 1978

    Article  PubMed  CAS  Google Scholar 

  • Lee C, Nguyen NB, Tran BK, et al. Quantification of magnesiumpancuronium interaction in the diaphragm and the tibialis anterior. Anesthesiology 57: A392, 1982

    Article  Google Scholar 

  • Lee DC, Liu HH, John TR. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission. Muscle and Nerve 6: 442–447, 1983

    Article  PubMed  CAS  Google Scholar 

  • Lincoff HA, Ellis CH, DeVoe AG, et al. The effect of succinylcholine on intraocular pressure. American Journal of Ophthalmology 40: 501–510, 1955

    PubMed  CAS  Google Scholar 

  • Marshall IG, Henderson F. Drug interactions at the neuromuscular junction. In Norman (Ed.) Neuromuscular blockade, Clinics in anaesthesiology, Vol. 3, No. 2, pp. 261–272, WB Saunders, London, 1985

    Google Scholar 

  • Matsuo S, Rao DBS, Chaudry I, Foldes FF. Interaction of muscle relaxants and local anesthetics at the neuromuscular junction. Anesthesia and Analgesia 57: 580–587, 1978

    PubMed  CAS  Google Scholar 

  • Meyers EF. Partial recovery from pancuronium neuromuscular blockade following hydrocortisone administration. Anesthesiology 46: 148–150, 1977

    Article  PubMed  CAS  Google Scholar 

  • Miller RD. Neuromuscular blocking agents. In Smith et al. (Eds) Drug interactions in anesthesia, pp. 249–269, Lea & Fibiger, Philadelphia, 1981

    Google Scholar 

  • Miller RD, Savarese JJ. Pharmacology of muscle relaxants and their antagonists. In Miller (Ed.) Anesthesia, 2nd ed, pp. 889–943, Churchill Livingstone, New York, 1986

    Google Scholar 

  • Miller RD, Way WL. Inhibition of succinylcholine-induced increased intragastric pressure by non-depolarizing muscle relaxants and lidocaine. Anesthesiology 34: 185–188, 1971

    Article  PubMed  CAS  Google Scholar 

  • Miller RD, Way WL, Katzung BG. The potentiation of neuromuscular blocking agents by quinidine. Anesthesiology 28: 1036–1041, 1967

    Article  PubMed  CAS  Google Scholar 

  • Mirakhur RK, Lavery TD, Briggs LP, et al. Effects of neostigmine and pyridostigmine on serum cholinesterase activity. Canadian Anaesthetists Society Journal 29: 55–58, 1982

    Article  PubMed  CAS  Google Scholar 

  • Ornstein E, Matteo RS, Schwarts AE, et al. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 67: 191–196, 1987

    Article  PubMed  CAS  Google Scholar 

  • Paton WDM. Histamine release by compounds of simple chemical structure. Pharmacological Reviews 9: 269, 1957

    PubMed  CAS  Google Scholar 

  • Paton WDM. The effects of muscle relaxants other than muscular relaxation. Anesthesiology 20, 453–463, 1959

    Article  PubMed  CAS  Google Scholar 

  • Richardson FJ, Agoston S. Neuromuscular blocking agents and skeletal muscle relaxants. In Meyler (Ed.) Side effects of drugs, 10th ed., pp. 204–231, Elsevier Science Publishers BV, Amsterdam, 1984

    Google Scholar 

  • Richardson FJ, Agoston S. Neuromuscular blocking agents and skeletal muscle relaxants. In Duke (Ed.) Side effects of drugs annual 10, pp. 107–114, Elsevier Science Publishers BV, Amsterdam, 1986

    Google Scholar 

  • Richardson FJ, Agoston S. Neuromuscular blocking agents and skeletal muscle relaxants. In Duke (Ed.) Side effects of drugs annual 11, pp. 120–128, Elsevier Science Publishers BV, Amsterdam, 1987

    Google Scholar 

  • Roth S, Ebrahim ZY. Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology 66: 691–693, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rupp SM, Miller RD, Gencarelli PJ. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane and halothane anesthesia in humans. Anesthesiology 60: 102–105, 1984

    Article  PubMed  CAS  Google Scholar 

  • Scappaticci KA, Ham JA, Sohn YJ, et al. Effects of furosemide on the neuromuscular junction. Anesthesiology 57: 381–388, 1982

    Article  PubMed  CAS  Google Scholar 

  • Scott RPF. Histamine release by muscle relaxants. In Azar I (Ed.) Muscle relaxants, pp. 39–56, Dekker Inc., New York, 1987

    Google Scholar 

  • Scott RPF, Savarese JJ. Autonomic responses to muscle relaxants. In Azar I (Ed.) Muscle relaxants, pp. 1–38, Dekker Inc., New York, 1987

    Google Scholar 

  • Singh YN, Marshall IG, Harvey AL. Pre- and postjunctional blocking effect of aminoglycoside, polymyxin, tetracycline and lincosamide antibiotics. British Journal of Anaesthesia 54: 1295–1306, 1982

    Article  PubMed  CAS  Google Scholar 

  • Sokoll MD, Gergis SD. Antibiotics and neuromuscular function. Anesthesiology 55: 148–159, 1981

    Article  PubMed  CAS  Google Scholar 

  • Sørensen M, Engbaek J, Viby-Mogensen J, et al. Bradycardia and cardiac asystole following single injection of suxamethonium. Acta Anaesthesiologica Scandinavica 28: 232–235, 1984

    Article  PubMed  Google Scholar 

  • Standaert FG. Release of transmitter at the neuromuscular junction. British Journal of Anaesthesia 54: 131–146, 1982

    Article  PubMed  CAS  Google Scholar 

  • Standaert FG. The doughnut and its hole. In Norman (Ed.) Neuromuscular blockade, Clinics in anaesthesiology, Vol. 3, No. 2, pp. 243–260, WB Saunders, London, 1985

    Google Scholar 

  • Swen J. Neuromuscular blocking agents: common interactions in daily clinical practice, ICG Printing, Dordrecht, 1985

  • Usubiaga JE. Neuromuscular effects of beta-adrenergic blockers. Anesthesiology 29: 484–492, 1968

    Article  PubMed  CAS  Google Scholar 

  • Usubiaga JE, Wikinski JA, Morales RL, et al. Interaction of intravenously administered procaine, lidocaine and succinylcholine in anesthetized subjects. Anesthesia and Analgesia 46: 39–45, 1967

    PubMed  CAS  Google Scholar 

  • van Nyhuis LS, Miller RD, Fogdall RP. The interaction between d-tubocurarine, pancuronium, polymyxin B and neostigmine on neuromuscular function. Anesthesia and Analgesia 55: 224–228, 1976

    PubMed  Google Scholar 

  • Vervloet D, Nizankowska E, Arnaud A, et al. Adverse reactions to suxamethonium and other muscle relaxants under general anesthesia. Journal of Allergy and Clinical Immunology 71: 552–559, 1983

    Article  PubMed  CAS  Google Scholar 

  • Viby-Mogensen J. Cholinesterase and succinylcholine. Danish Medical Bulletin 30: 129–150, 1983

    PubMed  CAS  Google Scholar 

  • Viby-Mogensen J. Interaction of other drugs with muscle relaxants. In Norman (Ed.) Neuromuscular blockade, Clinics in anaesthesiology, Vol. 3, No. 2, pp. 467–482, Saunders, London, 1985

    Google Scholar 

  • Viby-Mogensen J, Hanel HK, Hansen E, Graae J. Serum cholinesterase activity in burned patients II: Anaesthesia, suxamethonium and hyperkalaemia. Acta Anaesthesiologica Scandinavica 19: 169–179, 1975

    Article  PubMed  CAS  Google Scholar 

  • Vizi E, Illes P, Ronai A, et al. The effect of lithium on acetylcholine release and synthesis. Neuropharmacology 11: 521–530, 1972

    Article  PubMed  CAS  Google Scholar 

  • Voetmann C, Jest P. A myasthenic reaction provoked by treatment with lithium carbonate. Ugeskrift for Laeger 140: 2375–2376, 1978

    PubMed  CAS  Google Scholar 

  • Wali FA. Interaction of verapamil with d-tubocurarine and cholinergic agonists at the the avian neuromuscular junction. Acta Anaesthesiologica Scandinavica 31: 15–20, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ward S. Pharmacokinetics of atracurium metabolites. 7th European Congress of Anaesthesiology, Vienna, June 1986. Abstract no. 836, 1986

  • Ward S, Weatherley BS. Pharmacokinetics of atracurium and its metabolites. British Journal of Anaesthesia 58: 6S–10S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Watkins J. Immunological effects of anaesthetic drug. In Ficher (Ed.) Adverse reactions, Clinics in anaesthesiology, Vol. 2, No. 3, pp. 463–484, WB Saunders, London, 1984

    Google Scholar 

  • Waud BE, Farrell L, Waud DR. Lithium and neuromuscular transmission. Anesthesia and Analgesia 61: 399–402, 1982

    Article  PubMed  CAS  Google Scholar 

  • Wood M. Neuromuscular blocking agents. In Wood et al. (Eds) Drugs and anesthesia, pp. 299–340, Williams & Wilkins, Baltimore, 1982

    Google Scholar 

  • Wright JM, Collier B. The site of neuromuscular block produced by polymyxin B and rolitetracycline. Canadian Journal of Physiology and Pharmacology 54: 926–936, 1976

    Article  PubMed  CAS  Google Scholar 

  • Zalman F, Perloff JK, Durant NN, et al. Acute respiratory failure following intravenous verapamil in Duchenne’s muscular dystrophy. American Heart Journal 105: 510–511, 1983

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesia, Herlev Hospital, University of Copenhagen, DK-2730, Herlev, Denmark

    Doris Østergaard, Jens Engbaek & Jørgen Viby-Mogensen

Authors
  1. Doris Østergaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jens Engbaek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jørgen Viby-Mogensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Østergaard, D., Engbaek, J. & Viby-Mogensen, J. Adverse Reactions and Interactions of the Neuromuscular Blocking Drugs. Med Toxicol Adverse Drug Exp 4, 351–368 (1989). https://doi.org/10.1007/BF03259917

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259917

Keywords

Search

Navigation